Hawk Kim

2.7k citations

111 papers · 1.5k indexed · h-index 22

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Hematology 77
- Acute Myeloid Leukemia Research 41
- Chronic Myeloid Leukemia Treatments 23
- Hematopoietic Stem Cell Transplantation 21
- Multiple Myeloma Research and Treatments 14
Genetics 37
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Chronic Lymphocytic Leukemia Research 14

Co-authors: Jae‐Cheol Jo (22 shared papers)Young Joo Min (20 shared papers)Yunsuk Choi (22 shared papers)Je‐Hwan Lee (28 shared papers)Eui‐Kyu Noh (11 shared papers)Jae-Hoo Park (16 shared papers)Jin Ho Baek (17 shared papers)Kyoo‐Hyung Lee (24 shared papers)
Journals: Blood (21 papers)Annals of Hematology (12 papers)Leukemia Research (8 papers)Biology of Blood and Marrow Transplantation (6 papers)PLoS ONE (6 papers)
Partner nations: South Korea United States Canada

In The Last Decade

Hawk Kim

107 papers receiving 1.4k citations

Peers

Countries citing papers authored by Hawk Kim

Since Specialization

Citations

This map shows the geographic impact of Hawk Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hawk Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hawk Kim more than expected).

Fields of papers citing papers by Hawk Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hawk Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hawk Kim. The network helps show where Hawk Kim may publish in the future.

Co-authors

The 25 scholars most cited alongside Hawk Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hawk Kim Line = papers co-authored together Hawk Kim links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 111 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia Blood ·Je‐Hwan Lee, Young‐Don Joo, Hawk Kim, Sung Hwa Bae, Min Kyoung Kim, Dae Young Zang, Junglim Lee, Gyeong Won Lee, Jung‐Hee Lee, Jae-Hoo Park, Dae‐Young Kim, Won-Sik Lee, Hun Mo Ryoo, Myung Soo Hyun, Hyo Jung Kim, Young Joo Min, Yae-Eun Jang, Kyoo‐Hyung Lee, (unknown)	2011	102
2	Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type Annals of Hematology ·Jae‐Cheol Jo, Misung Kim, Yunsuk Choi, Hyun Jung Kim, Ji Eun Kim, Seoung Wan Chae, Hawk Kim, Hee Jeong	2016	84
3	Randomized Trial of Myeloablative Conditioning Regimens: Busulfan Plus Cyclophosphamide Versus Busulfan Plus Fludarabine Journal of Clinical Oncology ·Je‐Hwan Lee, Young‐Don Joo, Hawk Kim, Hun Mo Ryoo, Min Kyoung Kim, Gyeong‐Won Lee, Jung‐Hee Lee, Won Sik Lee, Jae-Hoo Park, Sung-Hwa Bae, Myung Soo Hyun, Dae‐Young Kim, Sung-Doo Kim, Young Joo Min, Kyoo‐Hyung Lee	2012	77
4	Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death Scientific Reports ·Sook‐Kyoung Heo, Eui‐Kyu Noh, Jeong Yi Kim, Yoo Kyung Jeong, Jae‐Cheol Jo, Yunsuk Choi, Su‐Jin Koh, Jin Ho Baek, Young Joo Min, Hawk Kim	2017	51
5	KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement Annals of Hematology ·(unknown), Hee‐Jin Kim, Hee Kyung Ahn, Chul Won Jung, Joon Ho Moon, Chang‐Hun Park, Ki-O Lee, Sun‐Hee Kim, Yeo‐Kyeoung Kim, Hyeoung‐Joon Kim, Sang Kyun Sohn, Sung Hyun Kim, Won Sik Lee, Kyoung Ha Kim, Yeung‐Chul Mun, Hawk Kim, Jinny Park, Woo-Sung Min, Hee‐Je Kim, Dong Hwan Dennis Kim	2012	49
6	Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Journal of Clinical Oncology ·Je‐Hwan Lee, Hawk Kim, Young‐Don Joo, Won-Sik Lee, Sung Hwa Bae, Dae Young Zang, Jihyun Kwon, Min Kyoung Kim, Junglim Lee, Gyeong Won Lee, Jung‐Hee Lee, Yunsuk Choi, Dae‐Young Kim, Eun‐Hye Hur, Sung-Nam Lim, Sangmin Lee, Hun Mo Ryoo, Hyo Jung Kim, Myung Soo Hyun, Kyoo‐Hyung Lee, (unknown)	2017	49
7	Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma Clinical Lymphoma & Myeloma ·Seok Jin Kim, Kihyun Kım, Byung‐Soo Kim, Hyo Jin Lee, Hawk Kim, Na-Ri Lee, Seung-Hyun Nam, Jung Hye Kwon, Hyo Jung Kim, Sang Kyun Sohn, Jong-Ho Won, Jae Hoon Lee, Cheolwon Suh, Sung‐Soo Yoon, Hye Jin Kim, Inho Kim, Young-Rok Do, Won Sik Lee, Young‐Don Joo, Ho Jin Shin	2008	48
8	A Prognostic Model of Therapy-Related Myelodysplastic Syndrome for Predicting Survival and Transformation to Acute Myeloid Leukemia Clinical Lymphoma Myeloma & Leukemia ·Alfonso Quintás‐Cardama, Naval Daver, Hawk Kim, Courtney D. DiNardo, Elias Jabbour, Tapan M. Kadia, Gautam Borthakur, Sherry Pierce, Jianqin Shan, Marylou Cárdenas-Turanzas, Jörge E. Cortes, Farhad Ravandi, William G. Wierda, Zeev Estrov, Stefan Faderl, Yue Wei, Hagop M. Kantarjian, Guillermo Garcia‐Manero	2014	45
9	Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation Biology of Blood and Marrow Transplantation ·Jin Seok Kim, Kihyun Kım, June‐Won Cheong, Yoo Hong Min, Cheolwon Suh, Hawk Kim, Deog Yeon Jo, Hun Mo Ryoo, Sung Soo Yoon, Jae Hoon Lee	2009	44
10	Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome Biology of Blood and Marrow Transplantation ·Deok‐Hwan Yang, Won Seog Kim, Seok Jin Kim, Sung Hwa Bae, Sung Hyun Kim, In Ho Kim, Sung Soo Yoon, Yeung‐Chul Mun, Ho‐Jin Shin, Yee Soo Chae, Jae-Yong Kwak, Hawk Kim, Min Kyoung Kim, Jin Seok Kim, Jong-Ho Won, Je‐Jung Lee, Cheol Won Suh	2009	42
11	High Dose Dexamethasone Vs. Conventional Dose Prednisolone for Adults with Immune Thrombocytopenia: a Prospective Multicenter Phase III Trial. Blood ·Sung Hwa Bae, Hun-Mo Ryoo, Won Sik Lee, Young Don Joo, Kyoo Hyung Lee, Je‐Hwan Lee, Jung‐Hee Lee, Hawk Kim, Jae Hoo Park, Min Kyoung Kim, Myung Soo Hyun, Ji Hoon Kim, Dae Young Zang	2010	30
12	Rosmarinic acid potentiates ATRA-induced macrophage differentiation in acute promyelocytic leukemia NB4 cells European Journal of Pharmacology ·Sook‐Kyoung Heo, Eui‐Kyu Noh, Dong‐Joon Yoon, Jae‐Cheol Jo, Su‐Jin Koh, Jin Ho Baek, Jae-Hoo Park, Young Joo Min, Hawk Kim	2014	27
13	Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study Group Leukemia & lymphoma ·Seok Jin Kim, Joon Ho Moon, Hawk Kim, Jin Seok Kim, Yu Yan Hwang, Tanin Intragumtornchai, Surapol Issaragrisil, Jae Yong Kwak, Je Jung Lee, Jong-Ho Won, Arry Harryanto Reksodiputro, Soon Thye Lim, Ann‐Lii Cheng, Won Seog Kim, Yok‐Lam Kwong	2012	27
14	Concurrent Male Gynecomastia and Testicular Hydrocele after Imatinib Mesylate Treatment of a Gastrointestinal Stromal Tumor Journal of Korean Medical Science ·Hawk Kim, Heung-Moon Chang, Min‐Hee Ryu, Tae‐Won Kim, Hee-Jung Sohn, So-Eun Kim, Hye‐Jin Kang, Sarah Park, Jung‐Shin Lee, Yoon‐Koo Kang	2005	27
15	Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer Cancer Chemotherapy and Pharmacology ·Jae‐Lyun Lee, Hye Jin Kang, Yoon‐Koo Kang, Min‐Hee Ryu, Heung Moon Chang, Tae‐Won Kim, Hee Jung Sohn, Hawk Kim, Jung Shin Lee	2007	26
16	A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome Leukemia Research ·Hawk Kim, Young Joo Min, Jin Ho Baek, Su Jin Shin, Eun-Hee Lee, Eui‐Kyu Noh, Mee-Young Kim, Jae-Hoo Park	2008	26
17	Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma Annals of Hematology ·Seok Jin Kim, Sung Yong Oh, Jin Seok Kim, Hawk Kim, Gyeong‐Won Lee, Jong-Ho Won, Ho Jin Shin, Deok Hwan Yang, Chul Won Choi, Jinny Park, Won Seog Kim, Cheolwon Suh	2010	23
18	Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity PLoS ONE ·Sook‐Kyoung Heo, Eui‐Kyu Noh, Dong‐Joon Yoon, Jae‐Cheol Jo, Jae-Hoo Park, Hawk Kim	2014	23
19	Expression of Programmed Cell Death 1 and Programmed Cell Death Ligand 1 in Extranodal NK/T-Cell Lymphoma, Nasal Type Blood ·Jae‐Cheol Jo, Yunsuk Choi, Hee Jeong, Eun Hee Lee, Eun Kyoung Kang, Hawk Kim	2015	23
20	Eosinophilic fasciitis preceding relapse of peripheral T-cell lymphoma Journal of Korean Medical Science ·Hawk Kim, Mi‐Ok Kim, Myung‐Ju Ahn, Young Yeol Lee, Tae June Jung, Il Young Choi, In Soon Kim, Chan Kum Park	2000	22

About Hawk Kim

Hawk Kim is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Immunology, having authored 111 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (41 papers), Chronic Myeloid Leukemia Treatments (23 papers), Lymphoma Diagnosis and Treatment (21 papers), Hematopoietic Stem Cell Transplantation (21 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (14 papers), Multiple Myeloma Research and Treatments (14 papers) and Viral-associated cancers and disorders (8 papers). The work is most often cited by research in Hematology (882 citations), Genetics (340 citations), Oncology (443 citations), Pathology and Forensic Medicine (256 citations) and Immunology (226 citations). Hawk Kim has collaborated with scholars based in South Korea, United States and Canada. Frequent co-authors include Jae‐Cheol Jo, Young Joo Min, Yunsuk Choi, Je‐Hwan Lee, Eui‐Kyu Noh, Jae-Hoo Park, Jin Ho Baek, Kyoo‐Hyung Lee, Young‐Don Joo and Jung‐Hee Lee. Their work appears in journals such as Blood, Annals of Hematology, Leukemia Research, Biology of Blood and Marrow Transplantation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact